Teva Pharmaceutical Industries — Ethics Grade F

Teva Pharmaceutical Industries receives an overall ethics grade of F (18/100) on CancelCo's corporate accountability database. Sector: Pharmaceuticals. Market cap: Large Cap.

Category scores

• labor: 45
• privacy: 60
• consumer: 10
• environment: 50
• humanRights: 40

Documented incidents (3)

• Opioid Crisis Settlement (high, 2022) — Agreed to a massive settlement to resolve thousands of lawsuits accusing the company of downplaying the addiction risks of opioid painkillers.
• Price Fixing Scheme (high, 2021) — The US DOJ charged Teva for conspiring to fix prices of generic drugs, resulting in inflated costs for consumers and healthcare systems.
• Kickbacks for Drug Promotion (medium, 2023) — Allegations surfaced regarding illegal kickbacks paid to doctors and pharmacies to ensure Teva products were preferred over competitors.

Documented good deeds

• Generic Access Initiative — Provided approximately $600M worth of critical medicines to low and middle-income countries through global health partnerships.

Ethical alternatives

• Viatris — More robust compliance programs and fewer active antitrust litigations compared to peers.